Narayana Hrudayalaya Ltd – Heart Surgeries, Cayman Beaches, and a 45x P/E Bill: ₹5,717 Cr Sales, ₹791 Cr PAT
1. At a Glance
Narayana Hrudayalaya (NH) is that hospital chain where bypass surgery is cheaper than your iPhone EMI, but the stock itself comes with a premium tag fatter than a hospital bill. With ₹5,717 Cr sales, ₹791 Cr profits, and 5,789 beds across 40 facilities, NH has built a business model that blends affordable healthcare with an investor P/E of 45x – basically, patients get discounts, shareholders don’t.
2. Introduction
Founded by Dr. Devi Shetty, Narayana Hrudayalaya made headlines by promising “healthcare for all” while running hospitals like low-cost airlines – high volume, thinner margins, but a packed house.
In India, they’ve built hospitals from Bangalore to Guwahati, with 36% revenue still coming from their Bangalore stronghold. And just to remind investors that they’re not a desi-only story, NH set up a beachside hospital in the Cayman Islands – where Indian heart surgeons now fix arteries of wealthy expats at dollar rates.
The pitch? They’re democratizing healthcare. The reality? With 45x P/E, the democratization hasn’t reached your demat account yet.
3. Business Model – WTF Do They Even Do?
NH runs on a mix of owned hospitals (70%), operated hospitals (27%), and heart centers (3%). Their specialties are distributed like your family WhatsApp groups:
Cardiac Sciences (32%) – bypasses and robotic surgeries.
Oncology (15%) – chemo + radiation, more powerful than your Netflix binge.
Medicine & GI (13%) – where acidity meets billion-dollar billing.
Renal (10%) – dialysis centers, because BP + sugar = lifelong subscription.
Others – neuro, ortho, pediatrics, pulmonology.
Payor Mix: 45% domestic walk-ins, 29% insured, 20% government schemes, 7% international. Translation: cash, cards, and a generous contribution from Ayushman Bharat.
4. Financials Overview
Metric
Latest Qtr (Jun’25)
YoY Qtr
Prev Qtr (Mar’25)
YoY %
QoQ %
Revenue (₹ Cr)
1,507
1,306
1,475
15.4%
2.2%
EBITDA (₹ Cr)
337
302
358
11.6%
-5.9%
PAT (₹ Cr)
196
202
197
-2.3%
-0.5%
EPS (₹)
9.6
9.8
9.7
-2.0%
-1.0%
Annualised EPS ~₹38.4. CMP ₹1,745 → P/E ~45.1x. Basically, the hospital treats low-cost, but the stock doesn’t.
